Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
ANVISA issues CGMP to Concord Biotech’s Unit I
ANVISA issues CGMP to Concord Biotech’s Unit I
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
InvaGen has received 5 inspectional observations in Form 483
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Subscribe To Our Newsletter & Stay Updated